Advancing Professional Development
We help the world breathe.
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.
Transforming Patient Care
Dupilumab Reduces Mucus in Patients’ Lungs; New Treatment Option for Moderate-to-Severe Asthma – New Study Published in AJRCCM
New research published in the American Journal of Respiratory and Critical Care Medicine shows that dupilumab reduces mucus buildup in the lungs of patients with moderate-to-severe asthma. The VESTIGE trial is the first to demonstrate this effect, offering a new treatment option that improves breathing and lung function. These findings mark a major advancement in asthma care and quality of life for affected patients.
-
-
Transforming Patient Care
ATS Breathe Easy Podcast: Controlling COPD with Controller Medication
-
-
Impacting Global Health
ATS 2026 Orlando: Deadline Approaching for Abstracts and Case Reports
-
-
Advancing Professional Development
Call for Abstracts: 2026 Innovation in Fellowship Education
Join Us
When you become a member of our global American Thoracic Society community of 30,000+ health care providers and researchers, you’ll have access to:
+ Cutting-edge science through ATS journals and publications.
+ Discounts on the Annual ATS International Conference, CME, and ATS Ed+ products.
+ A robust, collaborative online medical community of peers in our ATS DocMatter Community.
Advance respiratory health globally with a donation
Every gift matters in the fight against respiratory disease, and helps the next generation. The ATS is committed to your professional growth and the advancement of thoracic medicine. Lend a hand, and together, we can create a world where every breath is a testament to progress in research, pulmonary, critical care, and sleep medicine.